Status | Study |
Completed |
Study Name: LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Condition: Ovarian Neoplasms Peritoneal Neoplasms Date: 2009-11-09 Interventions: Drug: Placebo comparator to BI |
Completed |
Study Name: Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers Condition: Peritoneal Neoplasms Date: 2008-04-23 Interventions: Drug: nanoparticulate paclitaxel This is a Phase 1, dose-escalation study with 6 cohorts of 1 - 6 patien |
Terminated |
Study Name: A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Condition: Ovarian Cancer Peritoneal Neoplasms Date: 2007-08-14 Interventions: Drug: Volociximab 15 mg/kg weekly, IV infusions, for 8 weeks or until disease progression or unacceptabl |
Active, not recruiting |
Study Name: Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin Condition: Peritoneal Neoplasms Date: 2007-07-16 Interventions: Behavioral: Questionnaire QOL Questionnaires taking a total of 10 minutes to complete. |
Completed |
Study Name: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer Condition: Fallopian Tube Cancer Peritoneal Neoplasms Date: 2006-09-28 Interventions: Drug: phenoxodiol 400mg phenox |
Terminated |
Study Name: A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis Condition: Peritoneal Neoplasms Date: 2006-07-14 Interventions: Procedure: Surgical debulking with peritonectomy |
Completed |
Study Name: Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis Condition: Peritoneal Neoplasms Intestinal Obstruction Date: 2006-06-01 Interventions: Drug: Octreotide LAR Octreotid |
Completed |
Study Name: Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy Condition: Ovarian Cancer Fallopian Tube Cancer Date: 2006-04-24 Interventions: Drug: Farletuzumab Weekly Farl |
Active, not recruiting |
Study Name: Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Cancer Peritoneal Neoplasms Date: 2006-04-21 Interventions: Drug: Topotecan |
Terminated |
Study Name: Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Date: 2006-02-03 |